ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$VOR:NASDAQ · Vor Biopharma Inc - US

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases.

More about this company

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Sector: health

Conviction from: NASDAQ

52-week range: 6.5026.00

2 tracked filer(s) hold this · 1 opened, 1 added, 0 trimmed in 30-SEP-2026

Aggregate 13FScore 68 — mean of 2 scored holder(s) · buyers (new/add) avg 68. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7275New buy343,037$6,545,1460.0%
Paul Tudor Jones / Tudor61Added +40%27,468$524,0890.0%

Beyond 13F — activists, insiders, politicians & research

Activist 13D filings daily digest →

FiledFormActivist% of classConviction
2026-04-21SCHEDULE 13D/ARA CAPITAL MANAGEMENT, L.P.19.9%Highfiling
2026-04-15SCHEDULE 13D/ARA CAPITAL MANAGEMENT, L.P.19.9%Highfiling
2026-04-10SCHEDULE 13D/ARA CAPITAL MANAGEMENT, L.P.19.9%Highfiling
2026-04-08SCHEDULE 13D/ARA CAPITAL MANAGEMENT, L.P.19.9%Highfiling
2026-04-01SCHEDULE 13D/ARA CAPITAL MANAGEMENT, L.P.19.9%Highfiling
2026-03-16SCHEDULE 13D/ARA CAPITAL MANAGEMENT, L.P.19.9%Highfiling

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.